Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer
Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenit...
Saved in:
| Published in | BMC microbiology Vol. 22; no. 1; pp. 7 - 12 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
04.01.2022
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC.
16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied.
Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. |
|---|---|
| AbstractList | Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. Results 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43–79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Conclusion Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. Results 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Conclusion Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. Keywords: Bladder cancer, Urogenital tract, Microbiota, PD-L1, Immune escape Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC.BACKGROUNDUrogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC.16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied.RESULTS16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied.Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients.CONCLUSIONOur study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43-79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. Abstract Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can upregulate PD-L1 expression in certain epithelial tumors to promote immune escape has been demonstrated. Thus, we hypothesized that the urogenital microbiota may be involved in the recurrence and progression of non-muscle invasive bladder cancer (NMIBC) by upregulating the PD-L1 expression. To test this hypothesis, we investigated the relationship between urogenital microbial community and PD-L1 expression in male patients with NMIBC. Results 16S rRNA gene sequencing was performed to analyse the composition of urogenital microbiota, and the expression of PD-L1 in cancerous tissues was detected by immunohistochemistry. The subjects (aged 43–79 years) were divided into PD-L1-positive group (Group P, n = 9) and PD-L1-negative group (Group N, n = 19) respectively based on their PD-L1 immunohistochemical results. No statistically significant differences were found in the demographic characteristics between group P and N. We observed that group P exhibited higher species richness (based on Observed species and Ace index, both P < 0.05). Furthermore, subgroup analysis showed that the increase in number of PD-L1 positive cells was accompanied by increased richness of urogenital microbiota. Significantly different composition of urogenital microbiota was found between group P and group N (based on weighted Unifrac and unweighted Unifrac distances metric, both P < 0.05). Enrichment of some bacterial genera (e.g., Leptotrichia, Roseomonas, and Propionibacterium) and decrease of some bacterial genera (e.g., Prevotella and Massilia) were observed in group P as compared with group N. These findings indicated that these genera may affect the expression of PD-L1 through some mechanisms to be studied. Conclusion Our study provided for the first time an overview of the association between urogenital microbiota and PD-L1 expression in male patients with NMIBC, indicating that urogenital microbiota was an important determinant of PD-L1 expression in male NMIBC patients. |
| ArticleNumber | 7 |
| Audience | Academic |
| Author | Li, Kun Huang, Pengcheng Wen, Yuehui Huang, Zehai Zeng, Jiarong Li, Biao Chen, Chunxiao Zhao, Jie Wu, Peng |
| Author_xml | – sequence: 1 givenname: Chunxiao surname: Chen fullname: Chen, Chunxiao – sequence: 2 givenname: Zehai surname: Huang fullname: Huang, Zehai – sequence: 3 givenname: Pengcheng surname: Huang fullname: Huang, Pengcheng – sequence: 4 givenname: Kun surname: Li fullname: Li, Kun – sequence: 5 givenname: Jiarong surname: Zeng fullname: Zeng, Jiarong – sequence: 6 givenname: Yuehui surname: Wen fullname: Wen, Yuehui – sequence: 7 givenname: Biao surname: Li fullname: Li, Biao – sequence: 8 givenname: Jie surname: Zhao fullname: Zhao, Jie – sequence: 9 givenname: Peng surname: Wu fullname: Wu, Peng |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34983384$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wB1ggS2xgkWI7D9sskMq0wEhTGAFdW47jTD1K7MF2hnbPD-dOp4VOhVAS2bK_c-x7cw6zPeedybLnBB8Twus3kVBe1zmmBL4Ss5w_yg5IyUhOCcd79-b72WGMS4wJ4wV7ku0XpeBFwcuD7NdF8AvjbFI9Orc6-Mb6pN7OfTIuWdX312g6rHxIyiV0apIJg3Wbue_Q_DSfEXR2tQomRusdsg6dq96guUoW5BH9tOkSffYuH8aoYWPq1iratUHve9W2JqCJctqEp9njTvXRPLsdj7KLD2ffJ5_y2ZeP08nJLNeVYCknXV2zohGCmKrhjcZctF1TNboRlWJQEyZlqZpa1DUGSmGhaVVghhUusVZFcZRNt76tV0u5CnZQ4Vp6ZeXNgg8LqUKycFNpcCFagltMO-hiB0cUFRW4xoa1rBEEvN5tvVZjM5hWQ71B9TumuzvOXsqFX0vOaEWrCgxe3RoE_2M0McnBRm36XjnjxyhpTaCSAnMO6MsH6NKPwUGrgKJYlBXH9C-1gH8gres8nKs3pvKkFgW8nDGgjv9BwdOawWoIWGdhfUfwekcATDJXaaHGGOX029dd9sX9pvzpxl3eAOBbAJIWYzCd1BC9BOGBW9heEiw30ZbbaEuItryJttw0gT6Q3rn_R_Qbjsj5Sg |
| CitedBy_id | crossref_primary_10_3389_fcimb_2024_1374944 crossref_primary_10_1038_s41585_025_01011_z crossref_primary_10_1177_11795549231206796 crossref_primary_10_3390_cancers15204984 crossref_primary_10_1016_j_prnil_2022_10_001 crossref_primary_10_3389_fimmu_2024_1471273 crossref_primary_10_3390_biomedicines11102816 crossref_primary_10_3389_fimmu_2022_911325 crossref_primary_10_1080_14712598_2024_2371543 crossref_primary_10_3390_biomedicines10071758 crossref_primary_10_1080_19490976_2024_2394166 crossref_primary_10_3389_fcimb_2022_1030315 crossref_primary_10_3390_jcm13164927 crossref_primary_10_1080_17460913_2024_2414671 crossref_primary_10_3390_diagnostics12092068 crossref_primary_10_1038_s41585_023_00784_5 crossref_primary_10_3390_ijms25031732 crossref_primary_10_3389_fimmu_2024_1428420 crossref_primary_10_1111_bph_16300 crossref_primary_10_3390_ijms25084562 crossref_primary_10_1016_j_urolonc_2024_07_004 crossref_primary_10_20517_mrr_2023_47 crossref_primary_10_3390_biomedicines10081783 crossref_primary_10_1016_j_heliyon_2023_e13012 crossref_primary_10_1016_j_isci_2024_111338 crossref_primary_10_3389_fimmu_2024_1507355 |
| Cites_doi | 10.1038/s41587-019-0104-4 10.7717/peerj.1373 10.1101/cshperspect.a016295 10.1245/s10434-018-6498-2 10.1186/gb-2011-12-6-r60 10.1016/j.jnci.2012.08.002 10.1038/s41598-017-16289-2 10.1002/eji.201444972 10.1038/nmeth.f.303 10.1016/j.anaerobe.2008.04.004 10.1099/jmm.0.001058 10.1038/nm.3568 10.1128/mSystems.01371-20 10.1038/s41467-018-07305-8 10.1186/1756-8722-6-74 10.1038/nmeth.2604 10.1016/S1040-8428(01)00128-7 10.1172/JCI126022 10.7717/peerj.2584 10.3389/fonc.2021.677605 10.1172/jci.insight.120608 10.1016/j.eururo.2019.08.016 10.1126/science.aao3290 10.1016/S0140-6736(16)30512-8 10.1016/j.eururo.2020.03.055 10.1016/j.immuni.2018.03.014 10.1126/science.aan3706 10.1172/JCI95376 10.1172/JCI96061 10.1007/s00262-004-0593-x 10.1111/jre.12410 10.1016/j.tim.2020.02.002 10.3389/fmicb.2015.00020 10.1038/s41585-018-0055-4 10.1128/AEM.03006-05 10.1126/science.1224203 10.1056/NEJMra1600266 10.1200/jco.2015.33.15_suppl.e15504 10.1128/mBio.01315-19 10.1038/s41596-019-0264-1 10.1128/CMR.12.1.97 10.1038/nrmicro.2017.44 10.1002/cncr.22588 10.1016/j.imbio.2016.10.011 10.1016/j.molcel.2019.09.030 10.1128/AEM.00062-07 10.3389/fcimb.2018.00167 10.1016/0035-9203(82)90153-5 10.3389/fcimb.2017.00488 10.1126/science.aar4060 10.3322/caac.21492 10.1186/2049-2618-1-16 10.1016/j.eururo.2018.12.043 10.1016/j.imbio.2011.05.005 |
| ContentType | Journal Article |
| Copyright | 2021. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
| Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QL 7T7 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12866-021-02407-8 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2180 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_e039d10d02f147fcb93529060e7d7b91 PMC8725255 A693693877 34983384 10_1186_s12866_021_02407_8 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IGS IHR INH INR ISR ITC KQ8 LK5 LK8 M1P M48 M7P M7R MM. M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB ~02 -A0 3V. ACRMQ ADINQ AGJBV C24 CGR CUY CVF ECM EIF NPM PMFND 7QL 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c597t-1f6673b991e5b8bc089dfb5bcb95a73490144ab69660b99a09c253070a040ca33 |
| IEDL.DBID | DOA |
| ISSN | 1471-2180 |
| IngestDate | Wed Aug 27 01:28:53 EDT 2025 Thu Aug 21 14:11:30 EDT 2025 Tue Aug 05 11:29:19 EDT 2025 Fri Jul 25 10:48:25 EDT 2025 Tue Jun 17 21:43:23 EDT 2025 Tue Jun 10 20:22:58 EDT 2025 Fri Jun 27 04:19:56 EDT 2025 Wed Feb 19 02:27:00 EST 2025 Tue Jul 01 04:31:38 EDT 2025 Thu Apr 24 23:06:01 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Urogenital tract PD-L1 Microbiota Bladder cancer Immune escape |
| Language | English |
| License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c597t-1f6673b991e5b8bc089dfb5bcb95a73490144ab69660b99a09c253070a040ca33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/e039d10d02f147fcb93529060e7d7b91 |
| PMID | 34983384 |
| PQID | 2620945802 |
| PQPubID | 42585 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_e039d10d02f147fcb93529060e7d7b91 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8725255 proquest_miscellaneous_2616963088 proquest_journals_2620945802 gale_infotracmisc_A693693877 gale_infotracacademiconefile_A693693877 gale_incontextgauss_ISR_A693693877 pubmed_primary_34983384 crossref_citationtrail_10_1186_s12866_021_02407_8 crossref_primary_10_1186_s12866_021_02407_8 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-04 |
| PublicationDateYYYYMMDD | 2022-01-04 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC microbiology |
| PublicationTitleAlternate | BMC Microbiol |
| PublicationYear | 2022 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | MC Markowski (2407_CR21) 2019; 75 C Quast (2407_CR55) 2013; 41(Database 2407_CR45 TZ DeSantis (2407_CR56) 2006; 72 A Ribas (2407_CR28) 2018; 359 H Tang (2407_CR10) 2018; 128 H Bi (2407_CR32) 2019; 68 J Zhang (2407_CR50) 2019; 37 T Magoč (2407_CR51) 2011; 27 JG Caporaso (2407_CR49) 2010; 7 M Hurwitz (2407_CR5) 2015; 33 EK Costello (2407_CR14) 2012; 336 L Shi (2407_CR7) 2013; 6 C Blank (2407_CR6) 2005; 54 M Trikha (2407_CR40) 2003; 9 2407_CR36 RC Edgar (2407_CR54) 2010; 26 J Chong (2407_CR59) 2020; 15 PJ Torres (2407_CR37) 2015; 3 SV Lynch (2407_CR26) 2016; 375 ER Eribe (2407_CR33) 2008; 14 RM Hicks (2407_CR19) 1982; 76 N Castaño-Rodríguez (2407_CR34) 2017; 7 L Zitvogel (2407_CR23) 2017; 15 A Dzutsev (2407_CR25) 2015; 45 C Pettenati (2407_CR20) 2018; 15 P Wu (2407_CR47) 2017; 7 F de Braud (2407_CR2) 2002; 41 P Wu (2407_CR22) 2018; 8 AD Willis (2407_CR27) 2020; 28 Z Gao (2407_CR35) 2015; 6 BA Inman (2407_CR48) 2007; 109 2407_CR29 S Groeger (2407_CR11) 2011; 216 JY Jang (2407_CR39) 2017; 52 C Sun (2407_CR9) 2018; 48 V Matson (2407_CR30) 2018; 359 RL Warren (2407_CR38) 2013; 1 ES Gollwitzer (2407_CR13) 2014; 20 LC Chan (2407_CR42) 2019; 129 T Tanaka (2407_CR41) 2014; 6 B Routy (2407_CR31) 2018; 359 Q Wang (2407_CR57) 2007; 73 M Babjuk (2407_CR16) 2019; 76 MS Zaghloul (2407_CR17) 2012; 24 K Fukumoto (2407_CR4) 2018; 25 T Rognes (2407_CR53) 2016; 4 RC Edgar (2407_CR52) 2013; 10 2407_CR15 M Zhang (2407_CR44) 2015; 53 F Bray (2407_CR1) 2018; 68 A Calcinotto (2407_CR43) 2018; 9 AM Kamat (2407_CR3) 2016; 388 W Ma (2407_CR24) 2021; 11 JH Cha (2407_CR8) 2019; 76 2407_CR12 MH Mostafa (2407_CR18) 1999; 12 N Colliou (2407_CR46) 2017; 127 N Segata (2407_CR58) 2011; 12 |
| References_xml | – volume: 37 start-page: 676 issue: 6 year: 2019 ident: 2407_CR50 publication-title: Nature biotechnology doi: 10.1038/s41587-019-0104-4 – volume: 3 year: 2015 ident: 2407_CR37 publication-title: PeerJ doi: 10.7717/peerj.1373 – volume: 6 issue: 10 year: 2014 ident: 2407_CR41 publication-title: Cold Spring Harbor perspectives in biology doi: 10.1101/cshperspect.a016295 – volume: 25 start-page: 2484 issue: 8 year: 2018 ident: 2407_CR4 publication-title: Ann Surg Oncol doi: 10.1245/s10434-018-6498-2 – volume: 12 start-page: R60 issue: 6 year: 2011 ident: 2407_CR58 publication-title: Genome biology doi: 10.1186/gb-2011-12-6-r60 – volume: 24 start-page: 151 issue: 4 year: 2012 ident: 2407_CR17 publication-title: Journal of the Egyptian National Cancer Institute doi: 10.1016/j.jnci.2012.08.002 – volume: 7 start-page: 15957 issue: 1 year: 2017 ident: 2407_CR34 publication-title: Scientific reports doi: 10.1038/s41598-017-16289-2 – volume: 45 start-page: 17 issue: 1 year: 2015 ident: 2407_CR25 publication-title: European journal of immunology doi: 10.1002/eji.201444972 – volume: 7 start-page: 335 issue: 5 year: 2010 ident: 2407_CR49 publication-title: Nature methods doi: 10.1038/nmeth.f.303 – volume: 14 start-page: 131 issue: 3 year: 2008 ident: 2407_CR33 publication-title: Anaerobe doi: 10.1016/j.anaerobe.2008.04.004 – volume: 68 start-page: 1471 issue: 10 year: 2019 ident: 2407_CR32 publication-title: Journal of medical microbiology doi: 10.1099/jmm.0.001058 – volume: 20 start-page: 642 issue: 6 year: 2014 ident: 2407_CR13 publication-title: Nature medicine doi: 10.1038/nm.3568 – ident: 2407_CR15 doi: 10.1128/mSystems.01371-20 – volume: 9 start-page: 4832 issue: 1 year: 2018 ident: 2407_CR43 publication-title: Nature communications doi: 10.1038/s41467-018-07305-8 – volume: 6 start-page: 74 issue: 1 year: 2013 ident: 2407_CR7 publication-title: Journal of hematology & oncology doi: 10.1186/1756-8722-6-74 – volume: 10 start-page: 996 issue: 10 year: 2013 ident: 2407_CR52 publication-title: Nature methods doi: 10.1038/nmeth.2604 – volume: 41 start-page: 89 issue: 1 year: 2002 ident: 2407_CR2 publication-title: Critical reviews in oncology/hematology doi: 10.1016/S1040-8428(01)00128-7 – volume: 129 start-page: 3324 issue: 8 year: 2019 ident: 2407_CR42 publication-title: The Journal of clinical investigation doi: 10.1172/JCI126022 – volume: 4 year: 2016 ident: 2407_CR53 publication-title: PeerJ doi: 10.7717/peerj.2584 – volume: 11 year: 2021 ident: 2407_CR24 publication-title: A Retrospective Study. Frontiers in oncology doi: 10.3389/fonc.2021.677605 – ident: 2407_CR45 doi: 10.1172/jci.insight.120608 – volume: 76 start-page: 639 issue: 5 year: 2019 ident: 2407_CR16 publication-title: European urology doi: 10.1016/j.eururo.2019.08.016 – volume: 26 start-page: 2460 issue: 19 year: 2010 ident: 2407_CR54 publication-title: Bioinformatics (Oxford, England) – volume: 359 start-page: 104 issue: 6371 year: 2018 ident: 2407_CR30 publication-title: Science (New York, NY) doi: 10.1126/science.aao3290 – volume: 388 start-page: 2796 issue: 10061 year: 2016 ident: 2407_CR3 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(16)30512-8 – ident: 2407_CR29 doi: 10.1016/j.eururo.2020.03.055 – volume: 9 start-page: 4653 issue: 13 year: 2003 ident: 2407_CR40 publication-title: Clinical cancer research : an official journal of the American Association for Cancer Research – volume: 48 start-page: 434 issue: 3 year: 2018 ident: 2407_CR9 publication-title: Immunity doi: 10.1016/j.immuni.2018.03.014 – volume: 359 start-page: 91 issue: 6371 year: 2018 ident: 2407_CR31 publication-title: Science (New York, NY) doi: 10.1126/science.aan3706 – volume: 127 start-page: 3970 issue: 11 year: 2017 ident: 2407_CR46 publication-title: The Journal of clinical investigation doi: 10.1172/JCI95376 – volume: 128 start-page: 580 issue: 2 year: 2018 ident: 2407_CR10 publication-title: The Journal of clinical investigation doi: 10.1172/JCI96061 – volume: 54 start-page: 307 issue: 4 year: 2005 ident: 2407_CR6 publication-title: Cancer immunology, immunotherapy : CII doi: 10.1007/s00262-004-0593-x – volume: 52 start-page: 447 issue: 3 year: 2017 ident: 2407_CR39 publication-title: Journal of periodontal research doi: 10.1111/jre.12410 – volume: 28 start-page: 329 issue: 5 year: 2020 ident: 2407_CR27 publication-title: Trends in microbiology doi: 10.1016/j.tim.2020.02.002 – volume: 6 start-page: 20 year: 2015 ident: 2407_CR35 publication-title: Frontiers in microbiology doi: 10.3389/fmicb.2015.00020 – volume: 15 start-page: 615 issue: 10 year: 2018 ident: 2407_CR20 publication-title: Nature reviews Urology doi: 10.1038/s41585-018-0055-4 – volume: 53 start-page: 398 issue: 6 year: 2015 ident: 2407_CR44 publication-title: Journal of microbiology (Seoul, Korea) – volume: 72 start-page: 5069 issue: 7 year: 2006 ident: 2407_CR56 publication-title: Applied and environmental microbiology doi: 10.1128/AEM.03006-05 – volume: 336 start-page: 1255 issue: 6086 year: 2012 ident: 2407_CR14 publication-title: Science (New York, NY) doi: 10.1126/science.1224203 – volume: 375 start-page: 2369 issue: 24 year: 2016 ident: 2407_CR26 publication-title: The New England journal of medicine doi: 10.1056/NEJMra1600266 – volume: 27 start-page: 2957 issue: 21 year: 2011 ident: 2407_CR51 publication-title: Bioinformatics (Oxford, England) – volume: 33 start-page: e15504 year: 2015 ident: 2407_CR5 publication-title: J Clin Oncol doi: 10.1200/jco.2015.33.15_suppl.e15504 – ident: 2407_CR36 doi: 10.1128/mBio.01315-19 – volume: 15 start-page: 799 issue: 3 year: 2020 ident: 2407_CR59 publication-title: Nature protocols doi: 10.1038/s41596-019-0264-1 – volume: 12 start-page: 97 issue: 1 year: 1999 ident: 2407_CR18 publication-title: Clinical microbiology reviews doi: 10.1128/CMR.12.1.97 – volume: 15 start-page: 465 issue: 8 year: 2017 ident: 2407_CR23 publication-title: Nature reviews Microbiology doi: 10.1038/nrmicro.2017.44 – volume: 109 start-page: 1499 issue: 8 year: 2007 ident: 2407_CR48 publication-title: Cancer doi: 10.1002/cncr.22588 – ident: 2407_CR12 doi: 10.1016/j.imbio.2016.10.011 – volume: 76 start-page: 359 issue: 3 year: 2019 ident: 2407_CR8 publication-title: Molecular cell doi: 10.1016/j.molcel.2019.09.030 – volume: 73 start-page: 5261 issue: 16 year: 2007 ident: 2407_CR57 publication-title: Applied and environmental microbiology doi: 10.1128/AEM.00062-07 – volume: 8 start-page: 167 year: 2018 ident: 2407_CR22 publication-title: Frontiers in cellular and infection microbiology doi: 10.3389/fcimb.2018.00167 – volume: 41(Database start-page: issue):D590-596 year: 2013 ident: 2407_CR55 publication-title: Nucleic acids research – volume: 76 start-page: 519 issue: 4 year: 1982 ident: 2407_CR19 publication-title: Transactions of the Royal Society of Tropical Medicine and Hygiene doi: 10.1016/0035-9203(82)90153-5 – volume: 7 start-page: 488 year: 2017 ident: 2407_CR47 publication-title: Frontiers in cellular and infection microbiology doi: 10.3389/fcimb.2017.00488 – volume: 359 start-page: 1350 issue: 6382 year: 2018 ident: 2407_CR28 publication-title: Science (New York, NY) doi: 10.1126/science.aar4060 – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 2407_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 1 start-page: 16 issue: 1 year: 2013 ident: 2407_CR38 publication-title: Microbiome doi: 10.1186/2049-2618-1-16 – volume: 75 start-page: 637 issue: 4 year: 2019 ident: 2407_CR21 publication-title: European urology doi: 10.1016/j.eururo.2018.12.043 – volume: 216 start-page: 1302 issue: 12 year: 2011 ident: 2407_CR11 publication-title: Immunobiology doi: 10.1016/j.imbio.2011.05.005 |
| SSID | ssj0017837 |
| Score | 2.4555795 |
| Snippet | Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that microbiota can... Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion that... Abstract Background Urogenital microbiota may be associated with the recurrence of bladder cancer, but the underlying mechanism remains unclear. The notion... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 7 |
| SubjectTerms | Adult Aged B7-H1 Antigen - metabolism Bacteria Bacteria - classification Bacteria - genetics Bacteria - isolation & purification Bladder Bladder cancer Cancer Care and treatment Composition Control Diagnosis Disease Progression Gene sequencing Genitourinary organs Humans Identification and classification Immune escape Immunohistochemistry Invasiveness Male Males Medical examination Methods Microbiota Microbiota (Symbiotic organisms) Microorganisms Middle Aged Muscles PD-L1 PD-L1 protein Recurrence Risk factors rRNA 16S Smoking Species richness Statistical analysis Subgroups Tobacco Tumors Urinary Bladder Neoplasms - metabolism Urinary Bladder Neoplasms - microbiology Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - urine Urogenital System - microbiology Urogenital tract |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkLKs-GFmQQEgcU1YmT2OaC-lQXsdUKWGlvlu04ZaWtUzZZRO_8cDyJd9sIqdd4osSe8XjG_vwNQu8VrYhOUxEz61OULNEmVrosYuDe55omVuRwOXl8XpxNsy-zfBY23JoAq1z7xM5Rl7WBPfJ9IE4XWc5J-vnqVwxVo-B0NZTQuI8eAHUZQLrYbJNwJcxnX-uLMrzYb7wvLgBy6xNoSGRiPliMOs7-_z3zraVpCJu8tQ6dbqPHIYDEB73Gn6B71j1FD_uSktfP0N_psvY2AaVA8Hjesyy16tOkbgEWpBaLazy67GJu1-LjGywMris8OY6_JvjkT8DGOjx3eOx_E0968tUGw64tPq9dfLlq_NfxyP1WgH_HhwvwYEt8BEa0fI6mpyc_js7iUGkhNj6haOOkguqf2seKNtdcG8JFWelcGy1yxWgGZ62Z0gVQeXopRYRJc_AWyvsAoyh9gbZc7ewOwtoIVhZEFWnJMkVSoXleVopXxnJbpTRCyXrIpQk05FANYyG7dIQXsleT9GqSnZokj9DHzTtXPQnHndKHoMmNJBBodw_q5YUM81FaQkWZkJKkVZKxynfUR6KCFMSykmmRROgd2IEEigwHGJwLtWoaOfr-TR4UUASRcsYi9CEIVbXvg1HhSoMfCWDVGkjuDST9HDbD5rW5yeBDGnlj8RF6u2mGNwEX52y9ApnEK4X6pSJCL3vr3PTbq41TyrMIsYHdDgZm2OLmPzuGcc7S3Oear-7-rV30KIXLILAhle2hrXa5sq99iNbqN908_AfvzTm3 priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKERIXxLuhBRmExAEFkjiJHSSE-lQXsdUKWKk3y3acstLWoUkWde_8cGaS7LYRFSeu8ViJ5-lxxt8Q8lqxItBRlPncQooSh9r4Suepj9j7QrPQZgleTh6fpMfT-PNpcrpBVu2OegbWN6Z22E9qWs3fXV4sP4HBf2wNXqTva_CxKZbSQmKMCYovbpHbEJk4Guo4vvqrwCEbW12cuXHeIDi1GP5_e-proWpYRnktLh3dJ_f6DSXd7TTgAdmw7iG507WYXD4iv6dVCTqCrUHoeNahLjXqw6RssExIzedLOjpvl-8aenBVG0PLgk4O_C8hPbzsa2UdnTk6hs-kkw6MtaZ4iktPSuefL2p4Ox25Xwrr4eneHD1aRfdRqarHZHp0-H3_2O87L_gGEozGDwvsBqph72gTLbQJRJYXOtFGZ4niLMZ_r7HSKUJ7ApUKMhMl6D0U-ASjGHtCNl3p7Bah2mQ8TwOVRjmPVRBlWiR5oURhrLBFxDwSrlguTQ9Ljt0x5rJNT0QqOzFJEJNsxSSFR96u5_zsQDn-Sb2HklxTIqB2-6CszmRvn9IGLMvDIA-iIox5AQuFnWkWpIHlOddZ6JFXqAcSITMc1uScqUVdy9G3r3I3xaaITHDukTc9UVHCGozqrzgAJxBla0C5M6AEmzbD4ZW6yZVJSGwdkMWJCCKPvFwP40ysk3O2XCBNCEJhEDo88rTTzvW6QWyCMRF7hA_0dsCY4Yib_WgRxwWPEsg9n_0PTm6TuxFeIcFjrHiHbDbVwj6HjV2jX7TW-gfkKkmS priority: 102 providerName: Scholars Portal |
| Title | Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34983384 https://www.proquest.com/docview/2620945802 https://www.proquest.com/docview/2616963088 https://pubmed.ncbi.nlm.nih.gov/PMC8725255 https://doaj.org/article/e039d10d02f147fcb93529060e7d7b91 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9NAEF_0RPBF_DZ6llUEHyRcsptkN75d73pcxZZSLRRflt1ko4XeRppUvHf_cGeStDYI-uJLHrITkszMzkcy8xtCXmteBIax1BcWUpQoNJmvTZ74iL0vDQ9tGmNz8mSaXC6i98t4eTDqC2vCWnjglnEnNuBpHgZ5wIowEkVmUggZ0iAJrMiFafrWGfi8XTLV_T8QkHftWmRkclKBFU6w2BZSZ0xhfNlzQw1a_582-cAp9QsmDzzQxT1ytwsd6Wn7yPfJDesekNvtMMnrh-TnYlOCNuAQEDpZtfhKtX43K2ssCNLr9TUdXzXRtqvp-e8qGFoWdHbufwjp6EdXFevoytEJPCadtbCrFcXvtXRaOv9qW8Hd6dh911j5TodrtF0beobqs3lEFhejT2eXfjdjwc8glaj9sMC5nwaiRBsbabJApnlhYgN8jrXgEf5ljbRJEMQTqHSQZixGO6Fh92ea88fkyJXOPiXUZKnIk0AnLBeRDlhqZJwXWhaZlbZg3CPhjuUq6wDIcQ7GWjWJiExUKyYFYlKNmJT0yNv9Nd9a-I2_Ug9RkntKhM5uToBCqU6h1L8UyiOvUA8UgmM4rL75ordVpcYf5-o0wfGHXArhkTcdUVHCO2S6a2YATiCeVo_yuEcJuzfrL-_UTXXWo1I4JCCNYhkwj7zcL-OVWBHnbLlFmhCEwsFJeORJq5379waxSc5l5BHR09seY_orbvW1wRaXgsWQZT77H5x8Tu4wbBbBD1bRMTmqN1v7AkK42gzITbEUA3JrOJrO5oNm78JxEkk4zoeffwH2EkX2 |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTgheEN8EBhgE4gFFS5wvBwmhde20sraqxirtzdiOMyp1yWhaoO_8PfyN3OWjW4S0t73GFyX2ne_DvvsdIW-llzqKsdiODIQovqu0LVUS2oi9z5XnmjjA4uTRODyc-l9Og9Mt8rephcG0ykYnloo6yTWeke8icHrsB9xhny9-2Ng1Cm9XmxYalVgcmfUvCNmKT4Me8PcdYwf9k_1Du-4qYGtwnpe2m2KnSwV-kQkUV9rhcZKqQGkVBzLyfLxX9KUKEbYSqKQTaxbgzpAg71riASio_G3fg1CmQ7a7_fHkeHNvEUG815Tm8HC3AO0fYpIvhOwYOtm8Zf7KLgH_24IrxrCdqHnF8h3cI3drl5XuVTJ2n2yZ7AG5VTWxXD8kf6aLHKQQm4_Q0azCdVrKj5N8iYlIcj5f08F56eVnS9q7zL6heUonPXvo0v7vOhs3o7OMjuA36aSCey0onhPTcZ7Z56sCvk4H2U-JGfe0O0eduaD7KLaLR2R6I1x4TDpZnpmnhCodR0noyJAlkS8dFiseJKnkqTbcpMyziNssudA18Dn235iLMgDioajYJIBNomST4Bb5sHnnooL9uJa6i5zcUCJkd_kgX5yJWgMI43hx4jqJw1LXj1KYKPi-sRM6JkoiFbsWeYNyIBCUI8OsnzO5Kgox-Hos9kJsu-jxKLLI-5oozWEOWtZFFLASiOPVotxpUYLW0O3hRtxErbUKcbnHLPJ6M4xvYiZeZvIV0rjAFA-Mk0WeVNK5mTewjXse9y0SteS2tTDtkWz2vcQ05xELILp9dv1vvSK3D09GQzEcjI-ekzsMS1HwOMzfIZ3lYmVegIO4VC_rXUnJt5tWBP8AULZ2og |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urogenital+Microbiota%3APotentially+Important+Determinant+of+PD-L1+Expression+in+Male+Patients+with+Non-muscle+Invasive+Bladder+Cancer&rft.jtitle=BMC+microbiology&rft.au=Chunxiao+Chen&rft.au=Zehai+Huang&rft.au=Pengcheng+Huang&rft.au=Kun+Li&rft.date=2022-01-04&rft.pub=BMC&rft.eissn=1471-2180&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=12&rft_id=info:doi/10.1186%2Fs12866-021-02407-8&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e039d10d02f147fcb93529060e7d7b91 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon |